Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

• Status: Terminated
• Trial end date: 2018-12-19
• Target enrollment: 0
• Participant gender: All

Summary

This observational study will evaluate the safety, efficacy, characteristics of patients, characteristics of physicians and quality of life in patients who are prescribed OZURDEX® as treatment for non-infectious uveitis of the posterior segment of the eye in France.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate

Criteria

Inclusion Criteria:

-Patient with non-infectious uveitis affecting the posterior segment of the eye.

Exclusion Criteria:

-Patient not residing in metropolitan France.